550 filings
Page 3 of 28
8-K
MBRX
Moleculin Biotech Inc
13 Nov 23
Moleculin Reports Third Quarter 2023 Financial Results
8:00am
8-K
MBRX
Moleculin Biotech Inc
7 Nov 23
Regulation FD Disclosure
8:45am
8-K
MBRX
Moleculin Biotech Inc
6 Nov 23
Regulation FD Disclosure
8:35am
8-K
MBRX
Moleculin Biotech Inc
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm
8-K
MBRX
Moleculin Biotech Inc
17 Oct 23
Regulation FD Disclosure
9:00am
8-K
MBRX
Moleculin Biotech Inc
6 Oct 23
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
MBRX
Moleculin Biotech Inc
2 Oct 23
Regulation FD Disclosure
8:40am
8-K
MBRX
Moleculin Biotech Inc
21 Sep 23
Regulation FD Disclosure
8:50am
8-K
MBRX
Moleculin Biotech Inc
18 Sep 23
Moleculin Announces New Positive Independent Report of No Cardiotoxicity in Annamycin
8:40am
8-K
MBRX
Moleculin Biotech Inc
14 Sep 23
Moleculin Announces Abstract Accepted for Poster Presentation at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
8:35am
DEF 14A
MBRX
Moleculin Biotech Inc
Definitive proxy
1 Sep 23
4:01pm
8-K/A
MBRX
Moleculin Biotech Inc
23 Aug 23
Regulation FD Disclosure
4:07pm
8-K
MBRX
Moleculin Biotech Inc
21 Aug 23
Amendments to Articles of Incorporation or Bylaws
5:17pm
PRE 14A
MBRX
Moleculin Biotech Inc
Preliminary proxy
21 Aug 23
5:12pm
8-K
MBRX
Moleculin Biotech Inc
21 Aug 23
Regulation FD Disclosure
7:30am
8-K
MBRX
Moleculin Biotech Inc
11 Aug 23
Moleculin Reports Second Quarter 2023 Financial Results
7:00am
8-K
MBRX
Moleculin Biotech Inc
10 Aug 23
Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones
4:05pm
10-Q
2023 Q2
MBRX
Moleculin Biotech Inc
Quarterly report
10 Aug 23
4:01pm
8-K
MBRX
Moleculin Biotech Inc
7 Aug 23
Regulation FD Disclosure
8:40am
8-K
MBRX
Moleculin Biotech Inc
3 Aug 23
Regulation FD Disclosure
8:45am